PRISM BioLab Co.,LTD

¥103.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:206AHealthcare
Country Japan
PE (Fwd) •••
TSR 2Y CAGR (50.10%)
Div yield —
ROE (37.89%)
Biotechnology
Beta (5Y) 1.47
PE TTM —
TSR TTM (30.87%)
Mkt cap ¥3.807B
ROIC (23.01%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥126
22.27%
(44.95%)
Hold 4|12|6|10|8
1Q26
2Q26
3Q26
4Q26
Earnings per share¥
1.07
1.15
1.12
1.13
(3.01%)
1.67%
4.02%
1.49%
Revenue¥M
469.5
470.4
469.7
477.5
10.23%
6.98%
8.05%
4.32%
Peers (US$24.17M)
Cap (US$)
PE
22.20M
27.32x
24.17M
—
Capital
TTM
5Y
10Y
Leveragex
0.427
0.955
0.647
EBIT/Intx
0.854
0.146
0.135
Own earn%
(37.21)
(4.96)
(15.33)
Sh yield%
42.43
31.71
31.67
Owners
Insiders/Inst%
8.85
64.59
Short interest%
1.46
SBC / revenue%
1.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
13–22
$1 testx
0.0
Incr. ROIC%
1